Clinical trial
Phase Ⅳ Clinical Trial, to Evaluate the Efficacy of the Enterovirus 71 (EV71) Inactivated Vaccine and Its Correlation With EV71 Antibody Level
NCT03903926 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase Ⅳ Clinical Trial, to Evaluate the Efficacy of the Enterovirus 71 (EV71) Inactivated Vaccine and Its Correlation With EV71 Antibody Level
- Lead sponsor
- Sinovac Biotech Co., Ltd
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 26, 2019
- Completion date
- October 30, 2020
- Enrollment
- 15,500 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.